赛诺医疗
(688108)
| 流通市值：46.13亿 | | | 总市值：46.13亿 |
| 流通股本：4.10亿 | | | 总股本：4.10亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 91,062,636.9 | 343,257,735.55 | 244,617,074.1 | 161,285,944.35 |
| 营业收入 | 91,062,636.9 | 343,257,735.55 | 244,617,074.1 | 161,285,944.35 |
| 二、营业总成本 | 114,616,671.01 | 417,456,565.2 | 301,656,954.4 | 203,874,673.63 |
| 营业成本 | 41,581,816.74 | 141,025,595.72 | 101,148,123.42 | 68,162,594.11 |
| 税金及附加 | 653,176.27 | 2,257,921.11 | 1,541,661.4 | 892,115.99 |
| 销售费用 | 16,580,041 | 63,198,787.52 | 46,672,649.14 | 31,514,848.96 |
| 管理费用 | 18,778,575.35 | 94,568,065.74 | 70,526,079.47 | 50,220,204.83 |
| 研发费用 | 36,009,056.49 | 114,095,491.84 | 80,498,702.34 | 52,417,509.01 |
| 财务费用 | 1,014,005.16 | 2,310,703.27 | 1,269,738.63 | 667,400.73 |
| 其中:利息费用 | 1,409,377.37 | 3,748,086.73 | 2,565,114.2 | 1,550,506.96 |
| 其中:利息收入 | -608,543.72 | 2,632,251.08 | 2,014,748.19 | 1,306,749.18 |
| 加:公允价值变动收益 | 38,732.23 | - | 30,208.06 | - |
| 加:投资收益 | 20,714,206.35 | -4,673,372.13 | -3,581,068.09 | -2,312,064 |
| 资产处置收益 | - | -1,406,057.97 | 29.49 | - |
| 资产减值损失(新) | -3,640,746.56 | -4,611,904.58 | -5,801,300.29 | -2,131,938.86 |
| 信用减值损失(新) | 29,434.59 | 1,405,569.58 | 212,644.09 | -683,886.24 |
| 其他收益 | 7,542,401.31 | 14,067,287.08 | 10,359,966.47 | 7,253,283.62 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,129,993.81 | -69,417,307.67 | -55,819,400.57 | -40,463,334.76 |
| 加:营业外收入 | 387,227.42 | 1,818,392.13 | 22,971.08 | 22,633.47 |
| 减:营业外支出 | 17,214.5 | 257,530.63 | 228,771.09 | 196,771.09 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,500,006.73 | -67,856,446.17 | -56,025,200.58 | -40,637,472.38 |
| 减:所得税费用 | -4,403,521.28 | -24,456,659.01 | -11,390,876.21 | -8,441,589 |
| 六、净利润 | 5,903,528.01 | -43,399,787.16 | -44,634,324.37 | -32,195,883.38 |
| 持续经营净利润 | 5,903,528.01 | -40,562,271 | -44,634,324.37 | -32,195,883.38 |
| 终止经营净利润 | - | -2,837,516.16 | - | - |
| 归属于母公司股东的净利润 | 2,498,599.75 | -39,630,042.94 | -41,746,244.78 | -29,611,147.98 |
| 少数股东损益 | 3,404,928.26 | -3,769,744.22 | -2,888,079.59 | -2,584,735.4 |
| (一)基本每股收益 | 0.01 | -0.1 | -0.1 | -0.07 |
| (二)稀释每股收益 | 0.01 | -0.1 | -0.1 | -0.07 |
| 八、其他综合收益 | -1,318,944.11 | 448,558.25 | 870,596.84 | 1,474,735.01 |
| 归属于母公司股东的其他综合收益 | -1,318,944.11 | 448,558.25 | 870,596.84 | 1,474,735.01 |
| 九、综合收益总额 | 4,584,583.9 | -42,951,228.91 | -43,763,727.53 | -30,721,148.37 |
| 归属于母公司股东的综合收益总额 | 1,179,655.64 | -39,181,484.69 | -40,875,647.94 | -28,136,412.97 |
| 归属于少数股东的综合收益总额 | 3,404,928.26 | -3,769,744.22 | -2,888,079.59 | -2,584,735.4 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-28 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |